Citizens JMP downgraded Teleflex (TFX) to Market Perform from Outperform without a price target The company this morning reported Q4 results ...

Citizens JMP raised the firm’s price target on Rhythm Pharmaceuticals (RYTM) to $81 from $75 and keeps an Outperform rating on the shares.

The broker raised its Coinbase price target to $475 from $400 while maintaining its market outperform rating on the stock.

Devin Ryan, Citizens JMP senior analyst, joins 'Closing Bell Overtime' to talk Coinbase earnings. What would Nike be without its iconic swoosh? Here's how the legendary logo came to be.

Ibotta (NYSE: IBTA), which operates the largest digital promotions network in North America, announced today that CEO and founder, Bryan Leach, will participate in a fireside chat at The Citizens JMP ...

OppFi (OPFI) shares dipped 4.9% in Wednesday midafternoon trading, adding to the prior trading session's retreat, after JMP analyst David Scharf downgraded the consumer finance company to Market ...

Gannett Co., Inc. (“Gannett”, “we”, “our”, or the “Company”) (NYSE: GCI) today announced that its Chairman and Chief Executive Officer, Michael Reed, ...

CSG® (NASDAQ: CSGS) today announced that the company will present at Citizens JMP’s Technology Conference at The Ritz Carlton, 600 Stockton Street, San Francisco, CA. The presentation will be held at ...

Coinbase Global (NASDAQ:COIN) had its price target boosted by JMP Securities from $400.00 to $475.00 in a research report ...

JMP Securities reiterated their market outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a ...

JMP Securities reiterated its Market Outperform rating on Digital Realty Trust (NYSE:DLR) with a steady price target of ...